GlassScriptPhysician profile
Josefa L Binker
NPI 1487603353
$3,464.27
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,552 · 2020: $250 · 2021: $125 · 2022: $1,498 · 2023: $14.86 · 2024: $24.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,239.12 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $462.04 | 2019-2020 | |
| Novo Nordisk INC | $350.70 | 2019 | |
| Glaxosmithkline, LLC. | $246.88 | 2019 | |
| Allergan, INC. | $202.47 | 2020-2022 | |
| Astrazeneca Uk Limited | $181.07 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2019 | |
| Esperion Therapeutics, INC. | $124.96 | 2021 | |
| Radius Health, INC. | $114.93 | 2019 | |
| Amarin Pharma, INC. | $102.40 | 2019 | |
| Lilly USA, LLC | $93.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $93.02 | 2019 | |
| Janssen Pharmaceuticals, INC | $88.71 | 2019 | |
| Abbvie INC. | $39.24 | 2023-2024 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josefa Binker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.